Back
ESC Professional Premium Access

The effect of empagliflozin on ketone bodies in patients with heart failure with reduced ejection fraction (Empire HF)

Session: New pathophysiological insights of heart failure
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Speaker: Doctor M. Omar (Odense, DK)
Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Massar Omar

Odense University Hospital, Odense (Denmark)
0 follower

5 more presentations in this session

Myocardial DNA damage combined with genotype predicts heart failure outcome in various underlying diseases

Speaker: Doctor Z. Dai (Tokyo, JP)

Access
Abstract
Slides
Video
Thumbnail

Interleukin 17A-correlated myocarditis in patients with psoriasis: cardiac recovery following secukinumab administration

Speaker: Doctor A. Frustaci (Rome, IT)

Access
Abstract
Slides
Video
Thumbnail

Pathophysiological role of epicardial adipose tissue and its phenotypes in patients with diabetes and cardiovascular comorbidities.

Speaker: Doctor S. Kotha (Leeds, GB)

Access
Abstract
Slides
Video
Thumbnail

The right ventricle is not spared by the cardiotoxic effects of chemotherapy for breast cancer. Results of SAFE trial.

Speaker: Doctor M. Del Bene (Florence, IT)

Access
Abstract
Slides
Video
Thumbnail

Transcriptional regulation of macrophage inflammation in the heart failure with preserved ejection fraction: a translational study

Speaker: Doctor E. Gorica (Zurich, CH)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

New pathophysiological insights of heart failure

Speakers: Doctor M. Omar, Doctor Z. Dai, Doctor A. Frustaci, Doctor S. Kotha, Doctor M. Del Bene...
Access
Video
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb